WEKO3
アイテム
{"_buckets": {"deposit": "f29cd698-24f7-436d-8971-7a4c294744d1"}, "_deposit": {"created_by": 1, "id": "44417", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "44417"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00044417", "sets": ["1"]}, "author_link": ["441403", "441406", "441401", "441402", "441404", "441396", "441407", "441395", "441398", "441397", "441399", "441400", "441405"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2002", "bibliographicIssueDateType": "Issued"}, "bibliographicPageEnd": "250", "bibliographicPageStart": "242", "bibliographicVolumeNumber": "27", "bibliographic_titles": [{"bibliographic_title": "Methods"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "A new method for quantitative measurement of brain acetylcholinesterase(AChE) activity in living human brain using positron emission tomography(PET) is described. We tested several radiolabeled lipophilic acetylcholine analogs, e.g., N-methylpiperidyl esters, which readily entered the brain via the blood-brain barrier, were hydrolyzed sselectively by AChE, and were then trapped in the brain. Among them, and tested and N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) was chosen as the tracer for PET. Quantitative measurement of cortical AChE was accomplished by fitting the time course of cerebral radioactivity concentration measured by PET and the metabolite-corrected arterial plasma input function using a nonlinear least-squares fitting method. Normal control studies with a wide range in age(24-89 years) showed no decrease in AChE activity in the cerebral cortex with age. Studies on patients with Alzheimers disease demonstrated a widespread reduction of AChE activity in the cerebral cortex (more profound in early-onse than in late-onset Alzheimers disease). Parkinsons disease and progressive supranuclear palsy, clinically similar disorders, could be differentiated with [11C]MP4A/PET studies. Simple methods without using an arterial input function are also proposed. The method provides a quantitative measure ot the cholinergic aspect of brain function and proved to be useful in diagnosis of neurodegenerative disorders including Alzheimers disease.", "subitem_description_type": "Abstract"}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1046-2023", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Namba, Hiroki"}], "nameIdentifiers": [{"nameIdentifier": "441395", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fukushi, Kiyoshi"}], "nameIdentifiers": [{"nameIdentifier": "441396", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nagatsuka, Shin-ichiro"}], "nameIdentifiers": [{"nameIdentifier": "441397", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iyo, Masaomi"}], "nameIdentifiers": [{"nameIdentifier": "441398", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shinotoh, Hitoshi"}], "nameIdentifiers": [{"nameIdentifier": "441399", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tanada, Shuji"}], "nameIdentifiers": [{"nameIdentifier": "441400", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Irie, Toshiaki"}], "nameIdentifiers": [{"nameIdentifier": "441401", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "難波 宏樹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "441402", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "福士 清", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "441403", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "長塚 伸一郎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "441404", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "篠遠 仁", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "441405", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "棚田 修二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "441406", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "入江 俊章", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "441407", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/44417", "pubdate": {"attribute_name": "公開日", "attribute_value": "2006-07-06"}, "publish_date": "2006-07-06", "publish_status": "0", "recid": "44417", "relation": {}, "relation_version_is_last": true, "title": ["Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates"], "weko_shared_id": -1}
Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates
https://repo.qst.go.jp/records/44417
https://repo.qst.go.jp/records/44417d14677cd-f3b6-46c6-8706-42daecf4d15a
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2006-07-06 | |||||
タイトル | ||||||
タイトル | Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Namba, Hiroki
× Namba, Hiroki× Fukushi, Kiyoshi× Nagatsuka, Shin-ichiro× Iyo, Masaomi× Shinotoh, Hitoshi× Tanada, Shuji× Irie, Toshiaki× 難波 宏樹× 福士 清× 長塚 伸一郎× 篠遠 仁× 棚田 修二× 入江 俊章 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | A new method for quantitative measurement of brain acetylcholinesterase(AChE) activity in living human brain using positron emission tomography(PET) is described. We tested several radiolabeled lipophilic acetylcholine analogs, e.g., N-methylpiperidyl esters, which readily entered the brain via the blood-brain barrier, were hydrolyzed sselectively by AChE, and were then trapped in the brain. Among them, and tested and N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) was chosen as the tracer for PET. Quantitative measurement of cortical AChE was accomplished by fitting the time course of cerebral radioactivity concentration measured by PET and the metabolite-corrected arterial plasma input function using a nonlinear least-squares fitting method. Normal control studies with a wide range in age(24-89 years) showed no decrease in AChE activity in the cerebral cortex with age. Studies on patients with Alzheimers disease demonstrated a widespread reduction of AChE activity in the cerebral cortex (more profound in early-onse than in late-onset Alzheimers disease). Parkinsons disease and progressive supranuclear palsy, clinically similar disorders, could be differentiated with [11C]MP4A/PET studies. Simple methods without using an arterial input function are also proposed. The method provides a quantitative measure ot the cholinergic aspect of brain function and proved to be useful in diagnosis of neurodegenerative disorders including Alzheimers disease. | |||||
書誌情報 |
Methods 巻 27, p. 242-250, 発行日 2002 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1046-2023 |